Owen-Schaub L B, Angelo L S, Radinsky R, Ware C F, Gesner T G, Bartos D P
Department of Immunology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Cancer Lett. 1995 Jul 20;94(1):1-8. doi: 10.1016/0304-3835(95)03834-j.
Fas/APO-1, a member of the NGF/TNF receptor superfamily expressed on the cell-surface of normal and malignant cells, is known to induce cell death by apoptosis. In the present study, we have investigated Fas/APO-1 gene defects in a human osteosarcoma cell line resistant to the apoptosis-inducing effects of anti-Fas. cDNA cloning and sequencing revealed that these cells contained both 'authentic' and mutant Fas/APO-1 containing a 63 base pair in-frame deletion spanning the transmembrane domain, designated DFas/APO-1. Direct evidence for the existence of a soluble Fas/APO-1 protein was obtained by immunoprecipitation and Western blotting. Taken together with prior studies demonstrating a role for Fas/APO-1 and Fas ligand, respectively, in tumor target cell killing by cytotoxic T-lymphocytes, production of soluble Fas/APO-1 might have significant implications in malignant disease pathogenesis.
Fas/APO-1是NGF/TNF受体超家族的成员,在正常细胞和恶性细胞的细胞表面表达,已知其可通过凋亡诱导细胞死亡。在本研究中,我们调查了一株对抗Fas凋亡诱导作用具有抗性的人骨肉瘤细胞系中的Fas/APO-1基因缺陷。cDNA克隆和测序显示,这些细胞同时含有“真实的”和突变的Fas/APO-1,后者在跨膜结构域含有一个63个碱基对的框内缺失,命名为DFas/APO-1。通过免疫沉淀和蛋白质免疫印迹获得了可溶性Fas/APO-1蛋白存在的直接证据。结合先前分别证明Fas/APO-1和Fas配体在细胞毒性T淋巴细胞杀伤肿瘤靶细胞中作用的研究,可溶性Fas/APO-1的产生可能对恶性疾病发病机制具有重要意义。